News

July 30, 2015

CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia

The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path), and TransCelerate BioPharma Inc. announce that Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia have been published for use and accessible on the CDISC website.

Explore

June 2, 2015

Authors Representing TransCelerate BioPharma Inc. Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting

A group of nine authors involved with TransCelerate BioPharma Inc. were honored with a Global Inspire Award at DIA’s 2015 Annual Meeting. The recipients of the Author(s) of the Year Award published “Defining a Central Monitoring Capability: Sharing the Experience of TransCelerate BioPharma’s Approach, Part 1,” in  DIA’s official, scientific, peer-reviewed journal, Therapeutic Innovation &…

Explore

May 5, 2015

Applied Clinical Trials: TransCelerate’s Placebo and SOC Data Sharing Initiative

Explore

May 5, 2015

Clinical Leader: TransCelerate Moves Forward With Electronic Label Initiative

Explore

April 27, 2015

Outsourcing-Pharma.com: TransCelerate CEO, leaders offer update on industry group’s activities

Explore

April 25, 2015

Applied Clinical Trials: TransCelerate’s eLabeling Initiative

Explore

April 22, 2015

Data De-identification & Anonymization White Paper From the Data Transparency Initiative

Review our Model Approach to Data De-identification and Anonymization of Individual Patient Data in Clinical Studies

Explore

April 21, 2015

Training Module From the SQT Initiative

Review our Principal Investigator Oversight Program  to support improved quality, enhanced patient safety and efficiency of study startup.

Explore

April 10, 2015

Outsourcing-Pharma.com: TransCelerate launches two new initiatives to accelerate clinical trials

Explore

April 8, 2015

TransCelerate BioPharma Launches Two New Global Initiatives That Aim to Improve Clinical Research

TransCelerate BioPharma Inc. announced the establishment of two new global initiatives which will accelerate and enhance clinical trials. Both initiatives – Placebo / Standard of Care Data Sharing and Electronic Labels for Clinical Trials (eLabels), aim to create solutions that will have a direct impact on patients, sponsors and investigative sites.

Explore